Cordeiro J M, Howlett S E, Ferrier G R
Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia, Canada.
Cardiovasc Res. 1994 Dec;28(12):1794-802. doi: 10.1093/cvr/28.12.1794.
The objectives were (1) to develop a cellular model of simulated ischaemia and reperfusion in isolated ventricular myocytes; (2) to determine effects of simulated ischaemia and reperfusion on calcium current (ICa), transient inward current (ITI) and contraction; and (3) to determine whether pharmacological agents which alter intracellular sodium and calcium loading affect signs of calcium overload in reperfusion in this model.
Electrical activity was recorded with conventional and voltage clamp techniques. Cell shortening was measured with a video edge detector. Myocytes were equilibrated in Tyrode solution, exposed to simulated ischaemia (hypoxia, acidosis, lactate, hyperkalaemia, glucose-free) for 20 min, and reperfused with Tyrode solution.
Ischaemia depolarised myocytes [-89(SEM 1) to -67(4) mV, p < 0.05], abbreviated action potential duration [APD90, 257(14) to 188(12) ms, p < 0.05], and abolished contractions. Contractions elicited by voltage clamp steps also were abolished in ischaemia; however, ICa decreased by only 51% [-0.98(0.08) to -0.50(0.06) nA, p < 0.05]. Signs of calcium overload, including aftercontractions, oscillatory afterpotentials, and ITI, occurred in 69% of myocytes in reperfusion. Upon reperfusion, both APD90 and ICa recovered slowly; however, contractions returned quickly and temporarily exceeded control. Amiloride during ischaemia and reperfusion lowered incidence of ITI in reperfusion, whereas nifedipine and lignocaine had no effect on ITI.
This model of ischaemia and reperfusion in ventricular myocytes shows many features of multicellular preparations, such as membrane depolarisation and action potential duration shortening during ischaemia, and appearance of oscillatory afterpotentials upon reperfusion. Inhibition of contraction during ischaemia and recovery of contraction in reperfusion are independent of changes in APD90 or ICa. Induction of aftercontractions, oscillatory afterpotentials, and ITI in reperfusion is associated with reduced peak ICa. Amiloride most probably decreased signs of calcium overload in early reperfusion by inhibiting sodium loading via Na+/H+ exchange. Additionally, amiloride may inhibit ITI directly by blocking Na+/Ca2+ exchange.
(1)建立离体心室肌细胞模拟缺血再灌注的细胞模型;(2)确定模拟缺血再灌注对钙电流(ICa)、短暂内向电流(ITI)和收缩的影响;(3)确定改变细胞内钠和钙负荷的药物是否会影响该模型再灌注时的钙超载迹象。
采用传统和电压钳技术记录电活动。用视频边缘检测器测量细胞缩短。将心肌细胞在台氏液中平衡,暴露于模拟缺血(缺氧、酸中毒、乳酸、高钾血症、无葡萄糖)环境20分钟,然后用台氏液再灌注。
缺血使心肌细胞去极化[-89(标准误1)至-67(4)mV,p<0.05],缩短动作电位时程[APD90,257(14)至188(12)ms,p<0.05],并使收缩消失。电压钳步阶诱发的收缩在缺血时也消失;然而,ICa仅下降51%[-0.98(0.08)至-0.50(0.06)nA,p<0.05]。钙超载迹象,包括后收缩、振荡后电位和ITI,在69%的再灌注心肌细胞中出现。再灌注时,APD90和ICa均缓慢恢复;然而,收缩迅速恢复并暂时超过对照。缺血和再灌注期间的氨氯地平降低了再灌注时ITI的发生率,而硝苯地平和利多卡因对ITI无影响。
这种心室肌细胞缺血再灌注模型显示出多细胞制剂的许多特征,如缺血时膜去极化和动作电位时程缩短,以及再灌注时振荡后电位的出现。缺血时收缩的抑制和再灌注时收缩的恢复与APD90或ICa的变化无关。再灌注时后收缩、振荡后电位和ITI的诱导与ICa峰值降低有关。氨氯地平很可能通过抑制Na+/H+交换减少钠负荷,从而降低早期再灌注时的钙超载迹象。此外,氨氯地平可能通过阻断Na+/Ca2+交换直接抑制ITI。